AlexisJamieFeuerMD(She/Her)

[Pronunciation: FOY-UR]

Physician

Dr. Feuer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 2012 - 2015
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2009 - 2012
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2009

PubMed

29 citations
Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Alexis J. Feuer, Ashley Thai, Ryan T. Demmer, Maria G. Vogiatzi
JAMA Pediatrics. 2016-12-01
50 citations
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers.
Osagie Ebekozien, Shivani Agarwal, Nudrat Noor, Anastasia Albanese-O'Neill, Jenise C. Wong
The Journal of Clinical Endocrinology and Metabolism. 2021-03-25
34 citations
Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
Alexis J. Feuer, Ryan T. Demmer, Ashley Thai, Maria G. Vogiatzi
Bone. 2015-09-01

Black People with COVID-19 More Likely to Develop Diabetic KetoacidosisJanuary 7th, 2021
ENDO 2016: A Centennial CelebrationMay 7th, 2016
Stimulant Use for ADHD Associated with Lower Bone Density in Young PeopleApril 3rd, 2016
Join now to see all